Cancer cell immunity in the crosshairs: Worth the expense?
Friday, June 3, 2016 - 11:10
in Biology & Nature
Scientists have found unique genetic alterations that could indicate whether expensive immune checkpoint inhibitors would be effective for a particular patient. Their study reports that genetic alterations affecting a part of the PD-L1 gene increases the production of the protein, allowing cancer cells to escape detection by the immune system.